Bio-Techne
TECH
557 hedge funds and large institutions have $11.2B invested in Bio-Techne in 2024 Q1 according to their latest regulatory filings, with 74 funds opening new positions, 205 increasing their positions, 182 reducing their positions, and 44 closing their positions.
68% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 44
13% more repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 182
5% more funds holding
Funds holding: 531 → 557 (+26)
0.27% more ownership
Funds ownership: 100.64% → 100.92% (+0.27%)
9% less call options, than puts
Call options by funds: $14.4M | Put options by funds: $15.7M
9% less capital invested
Capital invested by funds: $12.3B → $11.2B (-$1.11B)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$197M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$123M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$90.1M |
| 4 |
Millennium Management
New York
|
+$82M |
| 5 |
Bank of New York Mellon
New York
|
+$25.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$273M |
| 2 |
Select Equity Group
New York
|
-$111M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$70.8M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$70.4M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$47.9M |
TECH Hedge Fund Activity: Q1 2024 in Review
557 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2024, worth a combined $11.2B — down 9.1% from $12.3B a quarter earlier.
Buyers outnumbered sellers: 74 funds opened new TECH positions and 44 closed out — a net gain of 30 holders — while 205 added to existing stakes and 182 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $197M. The largest seller was Neuberger Berman Group, cutting an estimated $273M.
- 557 institutional investors held Bio-Techne (TECH) as of Q1 2024, up from 531 in Q4 2023.
- Funds reported $11.2B of Bio-Techne stock for Q1 2024, down 9.1% quarter-over-quarter.
- 74 funds opened new Bio-Techne positions in Q1 2024 and 44 closed out, a net change of +30 holders.
- The largest Bio-Techne buyer in Q1 2024 was T. Rowe Price Associates, an estimated $197M added.
- The largest Bio-Techne seller in Q1 2024 was Neuberger Berman Group, an estimated $273M sold.
Based on aggregated 13F filings for Q1 2024.